Mon panier

IL-7

IL-7 Informations sur la molécule

Nom anglaisInterleukin-7Nombre de médicaments commercialisés0
Nombre de médicaments cliniques5Alias de la cibleInterleukin 7,IL7
Phase de R&D la plus avancéePhase 1 Clinical
Nom anglaisInterleukin-7
Alias de la cibleInterleukin 7,IL7
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques5
Phase de R&D la plus avancéePhase 1 Clinical

IL-7 Liste de produits

  • Attribut

    Protein (12)Antibody (1)Kits (2)

  • Bibliothèque de produits

    En ligne (15)

  • Espèces

    Human (12)Mouse (2)Cynomolgus (1)

  • Étiquette

    Tag Free (8)Fc Tag (1)His Tag (2)- (3)His Tag & Avi Tag (1)

  • Marqueur

    Unconjugated (12)- (2)Biotin-labeled (1)

IL-7Contexte de la molécule

Interleukin 7 is also known as IL7, IL-7, and is a hematopoietic growth factor secreted by stromal cells in the red marrow and thymus. It is also produced by keratinocytes, dendritic cells, hepatocytes, neurons, and epithelial cells, but is not produced by lymphocytes. IL-7 stimulates the differentiation of multipotent (pluripotent) hematopoietic stem cells into lymphoid progenitor cells, It also stimulates proliferation of all cells in the lymphoid lineage (B cells, T cells and NK cells). It is important for proliferation during certain stages of B-cell maturation, T and NK cell survival, development and homeostasis. IL-7 is a cytokine important for B and T cell development. This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. IL-7 binds to the IL-7 receptor, a heterodimer consisting of Interleukin-7 receptor alpha and common gamma chain receptor. Il-7 promotes hematological malignacies (acute lymphoblastic leukemia, T cell lymphoma). Elevated levels of IL-7 have also been detected in the plasma of HIV-infected patients. IL-7 as an immunotherapy agent has been examined in many pre-clinical animal studies and more recently in human clinical trials for various malignancies and during HIV infection. IL-7 could also be beneficial in improving immune recovery after allogenic stem cell transplant.

IL-7Alias de la molécule

IL7,Interleukin-7

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Anti-GPC3 chimeric antigen receptor T cell therapy (Hunan Zhaotai Yongren Biotech/Guangdong Zhaotai Invivo Biomedicine)Phase 1 ClinicalGuangdong Zhaotai Invivo Biomedicine Co Ltd, Hunan Zhaotai Yongren Biotech Co LtdCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung
Details
HCW-9206HCW-9206Phase 1 ClinicalHCW Biologics IncLeukemia, Myeloid, Acute; Solid tumours
Details
ADP-TILIL7ADP-TILIL7Phase 1 ClinicalAdaptimmune Therapeutics PlcMelanoma
Details
GSK-3888130-BGSK3888130B; GSK-3888130; GSK-3888130-BPhase 1 ClinicalGlaxosmithkline PlcColitis, Ulcerative; Multiple Sclerosis
Details
BNT-152BNT-152Phase 1 ClinicalBiontech SeSolid tumours
Details

Avis sur les produits

  • Informations sur la molécule
  • Liste de produits
  • Avis sur les produits
  • Informations sur les médicaments cliniques